This correlative analysis suggests that persistent CAR19 populations mediate on-target but off-tumor antigen targeting of progenitor B-cells in the marrow with subsequent consumption of B-cells, likely at the time of CD19 expression during lineage differentiation. The gene discussed is CD19; the disease is neoplasm.